핵의학 장비 시장 분석 및 예측 : 유형별, 제품 유형별, 서비스별, 기술별, 구성부품별, 용도별, 최종 사용자별, 설치 유형별, 모드별, 단계별(-2035년)

The Nuclear Medicine Equipment Market is expected to expand from $4.5 billion in 2025 to $8.2 billion by 2035, with a CAGR of approximately 6.2%. In 2025, the Nuclear Medicine Equipment Market was estimated to have a volume of 1,200 units, with projections to reach 2,000 units by 2035. The Single Photon Emission Computed Tomography (SPECT) segment currently holds the largest market share at 45%, followed by Positron Emission Tomography (PET) at 35%, and hybrid imaging systems at 20%. The SPECT segment's dominance is driven by its cost-effectiveness and widespread application in cardiology and oncology. Key players in the market include Siemens Healthineers, GE Healthcare, and Philips Healthcare, each playing a pivotal role in advancing technology and expanding market reach.

The competitive landscape is heavily influenced by these companies' strategic initiatives, such as Siemens Healthineers' investment in AI-enhanced imaging and GE Healthcare's focus on expanding its PET tracer portfolio. Regulatory frameworks, particularly the FDA and European Medicines Agency guidelines, significantly impact market operations, emphasizing compliance and innovation. Future projections indicate a robust growth trajectory, with a higher annual increase in R&D investment anticipated by 2035. This growth is driven by technological advancements and an increasing prevalence of chronic diseases. However, challenges such as high equipment costs and stringent regulatory approvals remain. The integration of AI and machine learning in imaging is expected to unlock new opportunities, enhancing diagnostic accuracy and operational efficiency.

The nuclear medicine equipment market is witnessing robust growth, driven by technological advancements and increasing demand for early diagnosis. The SPECT (Single Photon Emission Computed Tomography) segment dominates due to its widespread application in cardiology and oncology. PET (Positron Emission Tomography) follows as the second-highest performing sub-segment, benefiting from its precision in detecting metabolic changes in tissues. Among regions, North America leads the market, supported by a well-established healthcare infrastructure and high adoption of advanced technologies. Europe ranks second, with significant contributions from Germany and the UK, driven by rising healthcare expenditure and research activities. In Asia-Pacific, China and India are emerging as lucrative markets due to expanding healthcare facilities and increasing awareness about nuclear medicine. The market's growth is further fueled by strategic collaborations and government initiatives promoting the adoption of nuclear medicine. Enhanced imaging capabilities and the integration of AI in diagnostics present lucrative opportunities for stakeholders.

Geographical Overview

The North American region dominates the nuclear medicine equipment market, primarily driven by the United States. The countrya™s advanced healthcare infrastructure and significant investment in research and development propel market growth. The presence of key market players and a high adoption rate of advanced technologies further enhance this region's leading position.

Europe follows closely, with Germany, France, and the United Kingdom being major contributors. These countries have a robust healthcare system and a strong focus on technological advancements. Government initiatives supporting nuclear medicine applications in diagnostics and treatment also play a crucial role.

In the Asia Pacific, the market is rapidly expanding. Countries like China and India are witnessing increased demand for nuclear medicine equipment. This growth is driven by rising healthcare expenditures and a growing awareness of modern diagnostic techniques. Additionally, government efforts to improve healthcare infrastructure contribute significantly to the market's expansion.

Latin America shows promising growth potential in the nuclear medicine equipment market. Brazil and Mexico are at the forefront, with increasing investments in healthcare infrastructure. The rising prevalence of chronic diseases and a growing demand for early diagnosis are key factors driving market growth in this region.

The Middle East and Africa region is gradually emerging in the nuclear medicine equipment market. The United Arab Emirates and South Africa are leading this growth. Investments in healthcare infrastructure and an increasing focus on advanced diagnostic techniques are significant contributors to the market's development in these regions.

Key Trends and Drivers

The Nuclear Medicine Equipment Market is experiencing robust growth, propelled by advancements in imaging technologies and increased prevalence of chronic diseases. Key trends include the integration of artificial intelligence in diagnostic imaging, enhancing accuracy and efficiency. This technological evolution is enabling early disease detection and personalized treatment plans, driving market expansion.

The growing geriatric population and rising cancer incidence are significant drivers, necessitating advanced diagnostic solutions. Governments and healthcare institutions are investing in nuclear medicine infrastructure, further fueling market growth. Additionally, the shift towards non-invasive diagnostic procedures is boosting demand for nuclear medicine equipment.

Opportunities are abundant in emerging markets where healthcare infrastructure is expanding. Companies focusing on cost-effective and innovative solutions are poised to capture significant market share. Furthermore, collaborations between research institutions and equipment manufacturers are fostering innovation, ensuring the market's continuous evolution and adaptation to emerging healthcare needs.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Installation Type
• 2.9 Key Market Highlights by Mode
• 2.10 Key Market Highlights by Stage

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 SPECT Imaging Systems
  • 4.1.2 PET Imaging Systems
  • 4.1.3 Planar Scintigraphy
  • 4.1.4 Hybrid Imaging
  • 4.1.5 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Gamma Cameras
  • 4.2.2 PET/CT Scanners
  • 4.2.3 SPECT/CT Scanners
  • 4.2.4 Cyclotrons
  • 4.2.5 Radiopharmaceuticals
  • 4.2.6 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Equipment Maintenance
  • 4.3.2 Consulting
  • 4.3.3 Training
  • 4.3.4 Installation
  • 4.3.5 Upgradation
  • 4.3.6 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Digital Imaging
  • 4.4.2 Analog Imaging
  • 4.4.3 Software Solutions
  • 4.4.4 Radiopharmaceutical Production
  • 4.4.5 Others
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Detectors
  • 4.5.2 Collimators
  • 4.5.3 Data Acquisition Systems
  • 4.5.4 Processing Units
  • 4.5.5 Display Systems
  • 4.5.6 Others
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Cardiology
  • 4.6.2 Oncology
  • 4.6.3 Neurology
  • 4.6.4 Orthopedics
  • 4.6.5 Endocrinology
  • 4.6.6 Nephrology
  • 4.6.7 Gastroenterology
  • 4.6.8 Pulmonology
  • 4.6.9 Others
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Hospitals
  • 4.7.2 Diagnostic Centers
  • 4.7.3 Research Institutes
  • 4.7.4 Academic Institutions
  • 4.7.5 Specialty Clinics
  • 4.7.6 Others
• 4.8 Market Size & Forecast by Installation Type (2020-2035)
  • 4.8.1 New Installation
  • 4.8.2 Retrofit Installation
  • 4.8.3 Others
• 4.9 Market Size & Forecast by Mode (2020-2035)
  • 4.9.1 Inpatient
  • 4.9.2 Outpatient
  • 4.9.3 Others
• 4.10 Market Size & Forecast by Stage (2020-2035)
  • 4.10.1 Preclinical
  • 4.10.2 Clinical
  • 4.10.3 Commercial
  • 4.10.4 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 End User
    • 5.2.1.8 Installation Type
    • 5.2.1.9 Mode
    • 5.2.1.10 Stage
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 End User
    • 5.2.2.8 Installation Type
    • 5.2.2.9 Mode
    • 5.2.2.10 Stage
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 End User
    • 5.2.3.8 Installation Type
    • 5.2.3.9 Mode
    • 5.2.3.10 Stage
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 End User
    • 5.3.1.8 Installation Type
    • 5.3.1.9 Mode
    • 5.3.1.10 Stage
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 End User
    • 5.3.2.8 Installation Type
    • 5.3.2.9 Mode
    • 5.3.2.10 Stage
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 End User
    • 5.3.3.8 Installation Type
    • 5.3.3.9 Mode
    • 5.3.3.10 Stage
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 End User
    • 5.4.1.8 Installation Type
    • 5.4.1.9 Mode
    • 5.4.1.10 Stage
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 End User
    • 5.4.2.8 Installation Type
    • 5.4.2.9 Mode
    • 5.4.2.10 Stage
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 End User
    • 5.4.3.8 Installation Type
    • 5.4.3.9 Mode
    • 5.4.3.10 Stage
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 End User
    • 5.4.4.8 Installation Type
    • 5.4.4.9 Mode
    • 5.4.4.10 Stage
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 End User
    • 5.4.5.8 Installation Type
    • 5.4.5.9 Mode
    • 5.4.5.10 Stage
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 End User
    • 5.4.6.8 Installation Type
    • 5.4.6.9 Mode
    • 5.4.6.10 Stage
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 End User
    • 5.4.7.8 Installation Type
    • 5.4.7.9 Mode
    • 5.4.7.10 Stage
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 End User
    • 5.5.1.8 Installation Type
    • 5.5.1.9 Mode
    • 5.5.1.10 Stage
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 End User
    • 5.5.2.8 Installation Type
    • 5.5.2.9 Mode
    • 5.5.2.10 Stage
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 End User
    • 5.5.3.8 Installation Type
    • 5.5.3.9 Mode
    • 5.5.3.10 Stage
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 End User
    • 5.5.4.8 Installation Type
    • 5.5.4.9 Mode
    • 5.5.4.10 Stage
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 End User
    • 5.5.5.8 Installation Type
    • 5.5.5.9 Mode
    • 5.5.5.10 Stage
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 End User
    • 5.5.6.8 Installation Type
    • 5.5.6.9 Mode
    • 5.5.6.10 Stage
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 End User
    • 5.6.1.8 Installation Type
    • 5.6.1.9 Mode
    • 5.6.1.10 Stage
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 End User
    • 5.6.2.8 Installation Type
    • 5.6.2.9 Mode
    • 5.6.2.10 Stage
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 End User
    • 5.6.3.8 Installation Type
    • 5.6.3.9 Mode
    • 5.6.3.10 Stage
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 End User
    • 5.6.4.8 Installation Type
    • 5.6.4.9 Mode
    • 5.6.4.10 Stage
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 End User
    • 5.6.5.8 Installation Type
    • 5.6.5.9 Mode
    • 5.6.5.10 Stage

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 GE Healthcare
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Siemens Healthineers
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Philips Healthcare
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Canon Medical Systems
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Fujifilm Holdings Corporation
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Hitachi Medical Systems
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Shimadzu Corporation
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Neusoft Medical Systems
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Mediso Medical Imaging Systems
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Digirad Corporation
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 SurgicEye
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 CMR Naviscan
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 DDD-Diagnostic
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Sofie Biosciences
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Medsight Technologies
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Gamma Medica
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Nordion
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Biosensors International
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Positron Corporation
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Cardiarc
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us